A. Kathrine Lie

About

A. Kathrine Lie is a distinguished researcher in oncologic imaging, with a primary focus on prostate cancer diagnostics. Her work bridges the gap between advanced magnetic resonance imaging (MRI) and positron emission tomography (PET) to improve tumor characterization and clinical decision-making. In her landmark 2012 study, Lie demonstrated the accuracy and clinical significance of routine pelvic MRI using a phased-array coil for detecting extraprostatic tumor extension—a critical factor in staging prostate cancer. This work, which has garnered 25 citations, helped establish surface-coil 1.5-T MRI as a reliable tool for identifying locally advanced disease, directly influencing treatment planning. More recently, Lie has explored multimodal imaging, comparing time curves from dynamic 18F-fluciclovine PET with dynamic contrast-enhanced MRI in primary prostate carcinomas. Though a smaller study with 4 citations, this innovative work addresses the pressing need to understand whether different imaging techniques provide complementary or redundant information, particularly during the initial perfusion phase. Lie’s contributions are shaping how clinicians integrate functional and anatomical imaging to better stage and manage prostate cancer, making her a key voice in the evolution of precision oncologic imaging.

Research Focus

Key Achievements

Top Papers

1. 1
   Routine pelvic MRI using phased-array coil for detection of extraprostatic tumour extension: accuracy and clinical significance

   25 citations · 2012
2. 2
   Comparison of time curves from dynamic 18F-fluciclovine positron emission tomography and dynamic contrast-enhanced magnetic resonance imaging for primary prostate carcinomas

   4 citations · 2018

Key Collaborators

Contact & Links